MSN Labs continues its commitment to expanding access to quality, affordable medicines in the Kingdom of Saudi Arabia, serving the healthcare needs of patients and communities across the country. Backed by the global strength of the MSN Group of Companies, MSN’s presence in Saudi Arabia is driven by scientific excellence, regulatory compliance, and strong local partnerships. Through a focused portfolio of branded generics and specialty therapies, MSN supports healthcare professionals in delivering effective treatment solutions that improve patient outcomes and contribute to the Kingdom’s evolving healthcare ecosystem.

Key Therapeutic Areas

Cardiovascular
CNS
Oncology
Respiratory
Antibacterials
Nephrology
Urology
Orthopedics
Rheumatology
Rheumatology
Anti-inflammatory
Diabetes
Immunology
Hematology
Dermatology
Gastroenterology

Address

Novadoz Hobail international ( Joint Venture between MSN Laboratories Arabia and Al-Hobail)
Address: 3155 Al Tahliyah St, Al Aqiq, Riyadh 13515

Adverse Event Reporting

mousa@al-hobail.com